170 related articles for article (PubMed ID: 9685858)
1. Association of loss of heterozygosity at the p53 locus with chemoresistance in osteosarcomas.
Goto A; Kanda H; Ishikawa Y; Matsumoto S; Kawaguchi N; Machinami R; Kato Y; Kitagawa T
Jpn J Cancer Res; 1998 May; 89(5):539-47. PubMed ID: 9685858
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity of the retinoblastoma and p53 genes in primary cervical carcinomas with human papillomavirus infection.
Kim JW; Lee CG; Han SM; Kim KS; Kim JO; Lee JM; Kim IK; Namkoong SE
Gynecol Oncol; 1997 Nov; 67(2):215-21. PubMed ID: 9367711
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma.
Feugeas O; Guriec N; Babin-Boilletot A; Marcellin L; Simon P; Babin S; Thyss A; Hofman P; Terrier P; Kalifa C; Brunat-Mentigny M; Patricot LM; Oberling F
J Clin Oncol; 1996 Feb; 14(2):467-72. PubMed ID: 8636759
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer.
Xing EP; Yang GY; Wang LD; Shi ST; Yang CS
Clin Cancer Res; 1999 May; 5(5):1231-40. PubMed ID: 10353761
[TBL] [Abstract][Full Text] [Related]
5. Mutation spectrum of the retinoblastoma gene in osteosarcomas.
Wadayama B; Toguchida J; Shimizu T; Ishizaki K; Sasaki MS; Kotoura Y; Yamamuro T
Cancer Res; 1994 Jun; 54(11):3042-8. PubMed ID: 8187094
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity, microsatellite instability and TP53 gene status in ovarian carcinomas.
Plisiecka-Hałasa J; Dansonka-Mieszkowska A; Kraszewska E; Dańska-Bidzińska A; Kupryjańczyk J
Anticancer Res; 2008; 28(2A):989-96. PubMed ID: 18507046
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity and microsatellite instability at the retinoblastoma locus in osteosarcomas.
Belchis DA; Meece CA; Benko FA; Rogan PK; Williams RA; Gocke CD
Diagn Mol Pathol; 1996 Sep; 5(3):214-9. PubMed ID: 8866236
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity of the retinoblastoma gene is correlated with the altered pRb expression in human endometrial cancer.
Semczuk A; Marzec B; Roessner A; Jakowicki JA; Wojcierowski J; Schneider-Stock R
Virchows Arch; 2002 Dec; 441(6):577-83. PubMed ID: 12461615
[TBL] [Abstract][Full Text] [Related]
9. The loss of heterozygosity in retinoblastoma and p53 suppressor genes as a prognostic indicator for head and neck cancer.
Gleich LL; Li YQ; Biddinger PW; Gartside PS; Stambrook PJ; Pavelic ZP; Gluckman JL
Laryngoscope; 1996 Nov; 106(11):1378-81. PubMed ID: 8914904
[TBL] [Abstract][Full Text] [Related]
10. A high degree of chromosomal instability at 13q14 in cutaneous squamous cell carcinomas: indication for a role of a tumour suppressor gene other than Rb.
O'Connor DP; Kay EW; Leader M; Murphy GM; Atkins GJ; Mabruk MJ
Mol Pathol; 2001 Jun; 54(3):165-9. PubMed ID: 11376129
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas.
Yamaguchi T; Toguchida J; Wadayama B; Kanoe H; Nakayama T; Ishizaki K; Ikenaga M; Kotoura Y; Sasaki MS
Anticancer Res; 1996; 16(4A):2009-15. PubMed ID: 8712735
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity for Rb locus and pRb immunostaining in laryngeal cancer: a clinicopathologic, molecular and immunohistochemical study.
Pietruszewska W; Klatka J; Borzecki A; Rieske P
Folia Histochem Cytobiol; 2008; 46(4):479-85. PubMed ID: 19141402
[TBL] [Abstract][Full Text] [Related]
13. Determination of the prognostic value of loss of heterozygosity at the retinoblastoma gene in osteosarcoma.
Heinsohn S; Evermann U; Zur Stadt U; Bielack S; Kabisch H
Int J Oncol; 2007 May; 30(5):1205-14. PubMed ID: 17390023
[TBL] [Abstract][Full Text] [Related]
14. Relationship between loss of heterozygosity at microsatellite loci and computerized nuclear morphometry in hepatocellular carcinoma.
Suzuki K; Hirooka Y; Tsujitani S; Yamane Y; Ikeguchi M; Kaibara N
Anticancer Res; 2000; 20(2B):1257-62. PubMed ID: 10810431
[TBL] [Abstract][Full Text] [Related]
15. Alterations of the p53, Rb and MDM2 genes in osteosarcoma.
Miller CW; Aslo A; Won A; Tan M; Lampkin B; Koeffler HP
J Cancer Res Clin Oncol; 1996; 122(9):559-65. PubMed ID: 8781571
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity at the p53, RB, DCC and APC tumor suppressor gene loci in human bladder cancer.
Miyamoto H; Shuin T; Ikeda I; Hosaka M; Kubota Y
J Urol; 1996 Apr; 155(4):1444-7. PubMed ID: 8632608
[TBL] [Abstract][Full Text] [Related]
17. MDM2 amplification and loss of heterozygosity at Rb and p53 genes: no simultaneous alterations in the oncogenesis of liposarcomas.
Schneider-Stock R; Walter H; Radig K; Rys J; Bosse A; Kuhnen C; Hoang-Vu C; Roessner A
J Cancer Res Clin Oncol; 1998; 124(10):532-40. PubMed ID: 9829856
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity of a locus in the chromosomal region 17p13.3 is associated with increased cell proliferation in astrocytic tumors.
Sarkar C; Chattopadhyay P; Ralte AM; Mahapatra AK; Sinha S
Cancer Genet Cytogenet; 2003 Jul; 144(2):156-64. PubMed ID: 12850379
[TBL] [Abstract][Full Text] [Related]
20. CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations.
Nielsen GP; Burns KL; Rosenberg AE; Louis DN
Am J Pathol; 1998 Jul; 153(1):159-63. PubMed ID: 9665476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
